
Latest News
IOF Welcomes Dr. Famida Jiwa as Chair of the Committee of National Societies
February 9, 2024
Following the elections held for the position of Chair of the International Osteoporosis Foundation (IOF) Committee of National Societies (CNS), Dr. Famida Jiwa, President and CEO, Osteoporosis Canada has been elected Chair for the term 2024-2028.
As Chair of the IOF CNS, Dr. Jiwa will be sitting on the Board of Trustees as an ex-officio member and her term as Chair of the CNS will formally start in April 2024, on the occasion of the Committee of National Societies Annual Meeting, planned in London on April 11, 2024.
Dr. Jiwa will have the opportunity to designate the Vice-Chair of the CNS, who will be introduced to all CNS Members during the CNS Annual Meeting in London.
Congratulations to Dr. Famida Jiwa.

OC MAKES THE NEWS – RECENT ITEMS
Recently launched Apo-Teriparatide Injection now as a listed benefit in Ontario
February 20, 2025
Latest News Recently launched Apo-Teriparatide Injection now as a listed benefit in Ontario February 20, 2025 Apo-Teriparatide Injection ™ is a generic alternative to Forteo®. Osteoporosis pharmacologic therapies are classified […]
2024 Gideon A. Rodan Excellence in Mentorship Award
August 16, 2024
Latest News 2024 Gideon A. Rodan Excellence in Mentorship Award Angela Cheung, M.D., Ph.D. is the recipient of the 2024 Gideon A. Rodan Excellence in Mentorship Award which is given […]
Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis.
May 31, 2024
Latest News Sandoz receives Health Canada approval for Jubbonti®, first and only denosumab biosimilar for treatment of osteoporosis. May 31, 2024 Health Canada has provided authorization to market Jubbonti® (denosumab […]